Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.
Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.
NMDP/Be The Match and the ASTCT seek to address inequities in HCT and cellular therapy.